Leukemia Clinical Trials in Atlanta

Showing 1241-1260 of 1,466 trials

A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

NCT00994123

A Phase 1-2 study of MM-121 in combination with standard therapy for non-small cell lung cancer (NSCLC).

Merrimack Pharmaceuticals162 participantsStarted Feb 2010

Birmingham, Alabama, United States • Tucson, Arizona, United States • Loma Linda, California, United States +35 more locations

COMPLETEDPhase 1< 1 mile

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

NCT01325558

This is a Phase I, open-label, multi-center, competitive enrollment and dose-escalation study of ALT-836 in combination with standard of care gemcitabine in participants who have locally advanced or metastatic solid tumors. The purpose of this study is to determine the maximum tolerated dose (MTD), and to assess the safety and pharmacokinetic profile of ALT-836 given with gemcitabine. The clinical benefit, progression-free survival and overall survival of study participants will also be assessed.

Locally Advanced Malignant NeoplasmMalignant Solid Tumour

Altor BioScience30 participantsStarted May 2011

Atlanta, Georgia, United States • Iowa City, Iowa, United States • Rochester, New York, United States +1 more locations

A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Leukemia Trials in Other Cities

Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

Seasonal Allergic Rhinitis In Pediatric Subjects

Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia

A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

Epoetin Alfa in Treating Anemia in Patients With Solid Tumors

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)

An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy

Metronomic Chemotherapy in Advanced Gastric Cancer

Other Conditions in Atlanta